Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: A molecular genetic and clinicopathological study

Journal of Cancer Research and Clinical Oncology

Volumn 127, Issue 3, 2001, Pages 187-192

  Cong, Wen Ming ^a   Bakker, Anke ^b   Swalsky, Patricia A ^b   Raja, Siva ^b   Woods, Jeff ^b   Thomas, Stephen ^b   Demetris, Anthony J ^b   Finkelstein, Sydney D ^b  

^a Oriental Hepato biliary Surgery Hospital   (China)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cholangiocarcinoma; Clinical prognosis; Loss of heterozygosity; Pathology; Tumor suppressor gene

Indexed keywords

8 HYDROXYGUANINE; DNA GLYCOSYLTRANSFERASE; PROTEIN P53;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CARCINOGENESIS; CLINICAL ARTICLE; COLON POLYPOSIS; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FEMALE; GENES, APC; GENES, DCC; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED;

EID: 0035026664     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320000194     Document Type: Article

References (32)

1. American Joint Committee on Cancer. AJCC Cancer Staging Handbook (1997) AJCC Cancer Staging Manual, 5th edn. Lippincott-Raven, Philadelphia, pp 97-99
2. Chevillard S, Radicella JP, Levalois C, Lebeau J, Poupon MF, Oudard S, Dutrillaux B, Boiteux S (1998) Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kideny tumors. Oncogene 16: 3083-3086
3. Cho KR, Fearon ER (1995) DCC: linking tumor suppressor genes and altered cell surface interactions in cancer? Eur J Cancer 31A: 1055-1060
4. Cong WM, Wu MC, Chen H, Zhang XH (1997) Primary liver tumors in China: a clinicopathological studies of 3,160 cases. Oncol Rep 4: 649-652
5. Ding SF, Delhanty JDA, Bowles L, Dooley JS, Wood CB, Habib NA (1993) Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma. Br J Cancer 67: 1007-1010
6. Fearon ER, Dang CV (1999) Cancer genetics: tumor suppressor meets oncogene. Curr Biol 9: R62-R65
7. Fearon ER (1996) DCC: is there a connection between tumorigenesis and cell guidance molecules? Biochim Biophys Acta 1288: M17-M23
8. Furubo S, Harada K, Shimonishi T, Katayanagi K, Tsui W, Nakanuma Y (1999) Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma. Histopathology 35: 230-240
9. Greenblatt MS, Harris CC (1995) Molecular genetics of lung cancer. Cancer Surv 25: 293-313
10. Holzinger F, Z'graggen K, Büchcler MW (1999) Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma. Ann Oncol 4: 122-126
11. Ishark KG, Anthony PP, Sobin LH (1994) Histological typing of tumours of the liver. International histological classification of tumours. World Health Orgnization 2nd edn. Springer, Berlin Heidelberg New York, pp 17-19
12. Jen J, Hoguen K, Piantadosi S, Liu ZF, Levitt RC, Sistonen P, Kinzler KW, Vogelstein B, Hamilton SR (1994) Allelic loss of chromsome 18q and prognosis in colorectal cancer. N Engl J Med 331: 213-221
13. Kanbour-Shakir A, Kounelis S, Papadaki H, Raptis S, Edwards RP, Kelley J, Price FC, Bakker A, Swalsky PA, Przygodzki R, Finkelstein SD (1996) Relationship of p53 genotype to second-look recurrence and survival in ovarian epithelial malignancy. Mol Diag 1: 121-129
14. Kang YK, Kim WH, Lee HW, Lee HK, Kim Y (1999) Mutation of p53 and K-ras,and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma. Lab Invest 79: 477-483
15. Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Pro Natl Acad Sci USA 68: 820-823
16. Knudson AG (1993) Antioncogenes and human cancer. Proc Natl Acad Sci USA 90: 10914-10921
17. Konishi M, Kikuchi-Yanoshita R, Tanaka K, Soto C, Tsuruta K, Maeda Y, Koike M, Tanaka S, Nakamura Y, Hattori N, Miyaki M (1993) Genetic changes and histopathological grade in human hepatocellular carcinoma. Jpn J Cancer Res 84: 893-899
18. Li ZH, Zheng J, Weiss LM, Shibata D (1994) c-K-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol 144: 303-309
19. Monden Y, Aral T, Asano M, Ohtsuka E, Aburatani H, Nishimura S (1999) Human MMh (OGG1) type la protein is a major enzyme for repair of 8-hydrooxyguanine lesion in human cells. Biochem Biophys Res Commun 258: 605-610
20. Nakanuma Y, Hoso M, Terada T (1997) Clinical and pathologic features of cholangiocarcinoma. In: Okuda K, Tabor E (eds) Liver cancer. Churchill Livingstone, New York, pp 279-290
21. Nakeeb A, Pitt HA, Sohn TA, Cloeman J, Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL (1996) Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224: 463-475
22. Offner S, Schmaus W, Witter K, Baretton GB, Schlimok G, Passlick B, Riethmüller G, Pantel K (1999) p53 gene mutations are not required for early dissemination of cancer cells. Proc Natl Acad Sci USA 96: 6942-6946
23. Polakis P (1999) The oncogenic activation of β-catenin. Curr Opin Genet Dev 9: 15-21
24. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359: 235-237
25. Roose J, Huls G, Beest M, Moerer P, Horn K, Goldschmeding R, Logtenberg T, Clevers H (1999) Synergy between tumors suppressor APC and the β-catenin-Tcf4 target Tcf1. Science 285: 1923-1926
26. Rosenquist TA, Zharkov DO, Grollman AP (1997) Cloning and characterization of a mammaliam 8-oxoguanine DNA glycosylase. Proc Natl Acad Sci USA 94: 7429-7434
27. Safatle-Ribeiro AV, Ribeiro U, Reynolds JC, Gama-Rodrigues JJ, Iyiya K, Kim R, Bakker A, Swalsky PA, Pinotti HW, Finkelstein SD (1996) Morphologic, histologic, and molecular similarities between adenocarcinomas arising in the gastric stump and the intact stomach. Cancer 78: 2288-2299
28. Shibata D, Reale MA, Lavin P, Silverman M, Fearon ER, Steele G Jr, Jessup JM, Loda M, Summerhayes IC (1996) The DCC protein and progresis in colorectal cancer. N Engl J Med 335: 1727-1732
29. Shinmura K, Kohno T, Kasai H, Koda K, Sugimura H, Yokota J (1998) Infrequent mutations of the hOGG1 gene, that is involved in the excision of 8-hydroxyguanine in damaged DNA, in human gastric cancer. Jpn J Cancer Res 89: 825-828
30. Tannapfel A, Engeland K, Weinans L, Katalinic A, Ohanss J, Wittekind C (1999) Expression of p73, a novel protein related to the p53 tumor suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver. B J Cancer 80: 1069-1074
31. Taoka H, Kawarala Y (1977) Intrahepatic bile duct carcinoma (cholangiocarcinoma). J Jpn Surg Soc 98: 484-490
32. Yumoto Y, Hanafusa T, Hada H, Morita T, Ooguchi S, Shingi N, Mitani T, Hamaya K, Koide N, Tsuji T (1995) Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma. J Gastroenterol Hepatol 10: 179-185